{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:05:14Z","timestamp":1781067914324,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development ZonMw","doi-asserted-by":"crossref","award":["836011022"],"award-info":[{"award-number":["836011022"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00228-018-2529-y","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T22:28:22Z","timestamp":1532730502000},"page":"1585-1591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-594X","authenticated-orcid":false,"given":"Robert B.","family":"Flint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"ter Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Spaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan C. A.","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinno H. P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"issue":"4","key":"2529_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1542\/peds.2005-1528","volume":"117","author":"J Koch","year":"2006","unstructured":"Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117(4):1113\u20131121. https:\/\/doi.org\/10.1542\/peds.2005-1528","journal-title":"Pediatrics"},{"issue":"12 Suppl","key":"2529_CR2","first-page":"7S","volume":"36","author":"AM Evans","year":"1996","unstructured":"Evans AM (1996) Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol 36(12 Suppl):7S\u201315S","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2529_CR3","doi-asserted-by":"publisher","first-page":"F188","DOI":"10.1136\/fn.82.3.F188","volume":"82","author":"M Kluckow","year":"2000","unstructured":"Kluckow M, Evans N (2000) Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 82(3):F188\u2013F194","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"2529_CR4","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1542\/peds.2008-2418","volume":"123","author":"S Noori","year":"2009","unstructured":"Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123(1):e138\u2013e144. https:\/\/doi.org\/10.1542\/peds.2008-2418","journal-title":"Pediatrics"},{"issue":"7","key":"2529_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jama.1996.03530310045031","volume":"275","author":"A Varvarigou","year":"1996","unstructured":"Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. Jama 275(7):539\u2013544","journal-title":"Jama"},{"issue":"4","key":"2529_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/14767058.2012.733775","volume":"26","author":"F Bagnoli","year":"2013","unstructured":"Bagnoli F, Rossetti A, Messina G, Mori A, Casucci M, Tomasini B (2013) Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. J Matern Fetal Neonatal Med 26(4):423\u2013429. https:\/\/doi.org\/10.3109\/14767058.2012.733775","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"2529_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.siny.2015.03.004","volume":"20","author":"N Evans","year":"2015","unstructured":"Evans N (2015) Preterm patent ductus arteriosus: a continuing conundrum for the neonatologist? Semin Fetal Neonatal Med 20(4):272\u2013277. https:\/\/doi.org\/10.1016\/j.siny.2015.03.004","journal-title":"Semin Fetal Neonatal Med"},{"issue":"9","key":"2529_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamapediatrics.2015.0987","volume":"169","author":"A Jain","year":"2015","unstructured":"Jain A, Shah PS (2015) Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr 169(9):863\u2013872. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.0987","journal-title":"JAMA Pediatr"},{"key":"2529_CR9","doi-asserted-by":"publisher","first-page":"CD003481","DOI":"10.1002\/14651858.CD003481.pub6","volume":"2","author":"A Ohlsson","year":"2015","unstructured":"Ohlsson A, Walia R, Shah SS (2015) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 2:CD003481. https:\/\/doi.org\/10.1002\/14651858.CD003481.pub6","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2529_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2710.2005.00630.x","volume":"30","author":"L Desfrere","year":"2005","unstructured":"Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM (2005) Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 30(2):121\u2013132. https:\/\/doi.org\/10.1111\/j.1365-2710.2005.00630.x","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"2529_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jpeds.2010.10.008","volume":"158","author":"T Gokmen","year":"2011","unstructured":"Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U (2011) Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 158(4):549\u2013554 e541. https:\/\/doi.org\/10.1016\/j.jpeds.2010.10.008","journal-title":"J Pediatr"},{"issue":"5","key":"2529_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","volume":"65","author":"D Hirt","year":"2008","unstructured":"Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 65(5):629\u2013636. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03118.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2529_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000355679","volume":"105","author":"P Lago","year":"2014","unstructured":"Lago P, Salvadori S, Opocher F, Ricato S, Chiandetti L, Frigo AC (2014) Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology 105(1):46\u201354. https:\/\/doi.org\/10.1159\/000355679","journal-title":"Neonatology"},{"issue":"1","key":"2529_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000335332","volume":"102","author":"R Neumann","year":"2012","unstructured":"Neumann R, Schulzke SM, Buhrer C (2012) Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 102(1):9\u201315. https:\/\/doi.org\/10.1159\/000335332","journal-title":"Neonatology"},{"issue":"4","key":"2529_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/clpt.2011.284","volume":"91","author":"C Dani","year":"2012","unstructured":"Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, Ciuti R, Bandinelli A, Martano C, Murru P, Messner H, Schena F, Mosca F (2012) High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther 91(4):590\u2013596. https:\/\/doi.org\/10.1038\/clpt.2011.284","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2529_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jped.2015.09.009","volume":"92","author":"LV Dornelles","year":"2016","unstructured":"Dornelles LV, Corso AL, Silveira Rde C, Procianoy RS (2016) Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns. J Pediatr 92(3):314\u2013318. https:\/\/doi.org\/10.1016\/j.jped.2015.09.009","journal-title":"J Pediatr"},{"issue":"4","key":"2529_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00246-012-0182-2","volume":"33","author":"U Meissner","year":"2012","unstructured":"Meissner U, Chakrabarty R, Topf HG, Rascher W, Schroth M (2012) Improved closure of patent ductus arteriosus with high doses of ibuprofen. Pediatr Cardiol 33(4):586\u2013590. https:\/\/doi.org\/10.1007\/s00246-012-0182-2","journal-title":"Pediatr Cardiol"},{"issue":"9449","key":"2529_CR18","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","volume":"364","author":"V Gournay","year":"2004","unstructured":"Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, Blanc T, Fichtner C, Savagner C, Gouyon JB, Flurin V, Thiriez G (2004) Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 364(9449):1939\u20131944. https:\/\/doi.org\/10.1016\/S0140-6736(04)17476-X","journal-title":"Lancet"},{"issue":"12","key":"2529_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Jama 319(12):1221\u20131238. https:\/\/doi.org\/10.1001\/jama.2018.1896","journal-title":"Jama"},{"issue":"6","key":"2529_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00431-016-2705-y","volume":"175","author":"JL Slaughter","year":"2016","unstructured":"Slaughter JL, Reagan PB, Bapat RV, Newman TB, Klebanoff MA (2016) Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals. Eur J Pediatr 175(6):775\u2013783. https:\/\/doi.org\/10.1007\/s00431-016-2705-y","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2529_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","volume":"17","author":"KD Rainsford","year":"2009","unstructured":"Rainsford KD (2009) Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 17(6):275\u2013342. https:\/\/doi.org\/10.1007\/s10787-009-0016-x","journal-title":"Inflammopharmacology"},{"issue":"4","key":"2529_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0009-9236(01)26448-0","volume":"70","author":"B Overmeire Van","year":"2001","unstructured":"Van Overmeire B, Touw D, Schepens PJ, Kearns GL, van den Anker JN (2001) Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 70(4):336\u2013343","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"2529_CR23","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1177\/0091270008323752","volume":"48","author":"N Gregoire","year":"2008","unstructured":"Gregoire N, Desfrere L, Roze JC, Kibleur Y, Koehne P (2008) Population pharmacokinetic analysis of ibuprofen enantiomers in preterm newborn infants. J Clin Pharmacol 48(12):1460\u20131468. https:\/\/doi.org\/10.1177\/0091270008323752","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"2529_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1365-2125.1985.tb02694.x","volume":"19","author":"EJ Lee","year":"1985","unstructured":"Lee EJ, Williams K, Day R, Graham G, Champion D (1985) Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol 19(5):669\u2013674","journal-title":"Br J Clin Pharmacol"},{"issue":"31","key":"2529_CR25","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1021\/bi900999z","volume":"48","author":"JJ Prusakiewicz","year":"2009","unstructured":"Prusakiewicz JJ, Duggan KC, Rouzer CA, Marnett LJ (2009) Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid. Biochemistry 48(31):7353\u20137355. https:\/\/doi.org\/10.1021\/bi900999z","journal-title":"Biochemistry"},{"issue":"6","key":"2529_CR26","doi-asserted-by":"publisher","first-page":"e1256","DOI":"10.1542\/peds.2008-1780","volume":"122","author":"A Cherif","year":"2008","unstructured":"Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, Kacem S (2008) Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 122(6):e1256\u2013e1261. https:\/\/doi.org\/10.1542\/peds.2008-1780","journal-title":"Pediatrics"},{"issue":"4","key":"2529_CR27","doi-asserted-by":"publisher","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","volume":"97","author":"O Erdeve","year":"2012","unstructured":"Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N (2012) Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 97(4):F279\u2013F283. https:\/\/doi.org\/10.1136\/archdischild-2011-300532","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"2529_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000079618","volume":"86","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Cossey V, Langhendries JP, Naulaers G, Vanhole C, Devlieger H, Van Overmeire B (2004) Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol Neonate 86(3):207\u2013211. https:\/\/doi.org\/10.1159\/000079618","journal-title":"Biol Neonate"},{"issue":"3","key":"2529_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1203\/PDR.0b013e31817d9bb0","volume":"64","author":"C Hammerman","year":"2008","unstructured":"Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, Nir A (2008) Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatr Res 64(3):291\u2013297. https:\/\/doi.org\/10.1203\/PDR.0b013e31817d9bb0","journal-title":"Pediatr Res"},{"issue":"3","key":"2529_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1651-2227.1997.tb08892.x","volume":"86","author":"JV Aranda","year":"1997","unstructured":"Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H, Papageorgiou A, Chemtob S (1997) Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 86(3):289\u2013293","journal-title":"Acta Paediatr"},{"issue":"10","key":"2529_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/0091270004268320","volume":"44","author":"N Gregoire","year":"2004","unstructured":"Gregoire N, Gualano V, Geneteau A, Millerioux L, Brault M, Mignot A, Roze JC (2004) Population pharmacokinetics of ibuprofen enantiomers in very premature neonates. J Clin Pharmacol 44(10):1114\u20131124. https:\/\/doi.org\/10.1177\/0091270004268320","journal-title":"J Clin Pharmacol"},{"key":"2529_CR32","unstructured":"De Klerk JVP NVB IM, Flint RB, Allegaert K, Reiss IKM, Simons SHP (2017) Ibuprofen resistance in preterm infants with patent ductus arteriosus after the first days of life. In: Pediatric Academic Societies Meeting ed"},{"issue":"12","key":"2529_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1211\/0022357011778070","volume":"53","author":"M Kato","year":"2001","unstructured":"Kato M, Nishida S, Kitasato H, Sakata N, Kawai S (2001) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol 53(12):1679\u20131685","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2529_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.bjp.0701415","volume":"122","author":"W Neupert","year":"1997","unstructured":"Neupert W, Brugger R, Euchenhofer C, Brune K, Geisslinger G (1997) Effects of ibuprofen enantiomers and its coenzyme a thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol 122(3):487\u2013492. https:\/\/doi.org\/10.1038\/sj.bjp.0701415","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2529_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/11595640-000000000-00000","volume":"51","author":"RF Cock De","year":"2012","unstructured":"De Cock RF, Allegaert K, Schreuder MF, Sherwin CM, de Hoog M, van den Anker JN, Danhof M, Knibbe CA (2012) Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. Clin Pharmacokinet 51(2):105\u2013117. https:\/\/doi.org\/10.2165\/11595640-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2529_CR36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1573396310666140228235815","volume":"10","author":"GM Pacifici","year":"2014","unstructured":"Pacifici GM (2014) Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus. Curr Pediatr Rev 10(3):216\u2013237","journal-title":"Curr Pediatr Rev"},{"key":"2529_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pedneo.2015.04.017","volume":"58","author":"H Olgun","year":"2016","unstructured":"Olgun H, Ceviz N, Kartal I, Caner I, Karacan M, Tastekin A, Becit N (2016) Repeated courses of oral ibuprofen in premature infants with patent ductus arteriosus: efficacy and safety. Pediatr Neonatol 58:29\u201335. https:\/\/doi.org\/10.1016\/j.pedneo.2015.04.017","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"2529_CR38","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1542\/peds.2008-2232","volume":"124","author":"J Richards","year":"2009","unstructured":"Richards J, Johnson A, Fox G, Campbell M (2009) A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 124(2):e287\u2013e293. https:\/\/doi.org\/10.1542\/peds.2008-2232","journal-title":"Pediatrics"},{"issue":"11","key":"2529_CR39","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00431-012-1805-6","volume":"171","author":"NM Lugt van der","year":"2012","unstructured":"van der Lugt NM, Lopriore E, Bokenkamp R, Smits-Wintjens VE, Steggerda SJ, Walther FJ (2012) Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus. Eur J Pediatr 171(11):1673\u20131677. https:\/\/doi.org\/10.1007\/s00431-012-1805-6","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2529_CR40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1124\/jpet.103.060137","volume":"308","author":"SB Koukouritaki","year":"2004","unstructured":"Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308(3):965\u2013974. https:\/\/doi.org\/10.1124\/jpet.103.060137","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2529_CR41","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1136\/archdischild-2014-306339","volume":"100","author":"A Rolland","year":"2015","unstructured":"Rolland A, Shankar-Aguilera S, Diomande D, Zupan-Simunek V, Boileau P (2015) Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch Dis Child Fetal Neonatal Ed 100(1):F55\u2013F58. https:\/\/doi.org\/10.1136\/archdischild-2014-306339","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2529-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:25:01Z","timestamp":1604701501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2529-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2529-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"30 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}